Evidence map›Paper›PMID 26787908›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Nuclear hormone receptor DHR96 mediates the resistance to xenobiotics but not the increased lifespan of insulin-mutant Drosophila.

Sonita Afschar, Janne M Toivonen, Julia Marianne Hoffmann, Luke Stephen Tain, Daniela Wieser, Andrew John Finlayson, Yasmine Driege, Nazif Alic, Sahar Emran, Julia Stinn and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.3field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 58 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Chili-supplemented food decreases glutathione-Redox report : communications in free radical research · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. TheeLife · 2020
    Article
  15. MAPK-directed activation of the whitefly transcription factorProceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 4 countries.

Sonita AfscharMax Planck Institute for Biology of Ageing, 50931 Cologne, Germany;
Janne M ToivonenLaboratorio de Genética Bioquímica, Departamento de Anatomía, Embriología y Genética Animal, Facultad de Veterinaria, Instituto Agroalimentario de Aragón, Instituto de Investigación Sanitaria Aragón, Universidad de Zaragoza, 50013 Zaragoza, Spain;
Julia Marianne HoffmannMax Planck Institute for Biology of Ageing, 50931 Cologne, Germany;ORCID http://orcid.org/0000-0002-9619-6292
Luke Stephen TainMax Planck Institute for Biology of Ageing, 50931 Cologne, Germany;
Daniela WieserWellcome Trust Genome Campus, European Bioinformatics Institute, Hinxton, Cambridge CB10 1SD, United Kingdom;
Andrew John FinlaysonMax Planck Institute for Biology of Ageing, 50931 Cologne, Germany;
Yasmine DriegeDepartment of Molecular Biomedical Research, Unit of Molecular Signal Transduction in Inflammation, Vlaams Instituut voor Biotechnologie, Zwijnaarde, B-9052, Ghent, Belgium; Department of Biomedical Molecular Biology, Ghent University, Zwijnaarde, B-9052, Ghent, Belgium;
Nazif AlicUniversity College London Institute of Healthy Ageing, and Department of Genetics, Evolution and Environment, University College London, London WC1E 6BT, United Kingdom.
Sahar EmranUniversity College London Institute of Healthy Ageing, and Department of Genetics, Evolution and Environment, University College London, London WC1E 6BT, United Kingdom.
Julia StinnMax Planck Institute for Biology of Ageing, 50931 Cologne, Germany;
Jenny FroehlichMax Planck Institute for Biology of Ageing, 50931 Cologne, Germany;
Matthew D PiperUniversity College London Institute of Healthy Ageing, and Department of Genetics, Evolution and Environment, University College London, London WC1E 6BT, United Kingdom.
Linda PartridgeMax Planck Institute for Biology of Ageing, 50931 Cologne, Germany; University College London Institute of Healthy Ageing, and Department of Genetics, Evolution and Environment, University College London, London WC1E 6BT, United Kingdom partridge@age.mpg.de.
Max Planck Institute for Biology of Ageing · DEUniversity College London · GBEuropean Bioinformatics Institute · GBUniversidad de Zaragoza · ESVlaams Instituut voor Biotechnologie · BE

Funding

Biotechnology and Biological Sciences Research Council BB/I011544/1Biotechnology and Biological Sciences Research Council BB/M029093/1European Research Council 268739Wellcome Trust WT081394
6 · The paper itself

Abstract

Lifespan of laboratory animals can be increased by genetic, pharmacological, and dietary interventions. Increased expression of genes involved in xenobiotic metabolism, together with resistance to xenobiotics, are frequent correlates of lifespan extension in the nematode worm Caenorhabditis elegans, the fruit fly Drosophila, and mice. The Green Theory of Aging suggests that this association is causal, with the ability of cells to rid themselves of lipophilic toxins limiting normal lifespan. To test this idea, we experimentally increased resistance of Drosophila to the xenobiotic dichlordiphenyltrichlorethan (DDT), by artificial selection or by transgenic expression of a gene encoding a cytochrome P450. Although both interventions increased DDT resistance, neither increased lifespan. Furthermore, dietary restriction increased lifespan without increasing xenobiotic resistance, confirming that the two traits can be uncoupled. Reduced activity of the insulin/Igf signaling (IIS) pathway increases resistance to xenobiotics and extends lifespan in Drosophila, and can also increase longevity in C. elegans, mice, and possibly humans. We identified a nuclear hormone receptor, DHR96, as an essential mediator of the increased xenobiotic resistance of IIS mutant flies. However, the IIS mutants remained long-lived in the absence of DHR96 and the xenobiotic resistance that it conferred. Thus, in Drosophila IIS mutants, increased xenobiotic resistance and enhanced longevity are not causally connected. The frequent co-occurrence of the two traits may instead have evolved because, in nature, lowered IIS can signal the presence of pathogens. It will be important to determine whether enhanced xenobiotic metabolism is also a correlated, rather than a causal, trait in long-lived mice.

Indexed as

MutationAnimalsDrosophilaDrosophila ProteinsDrug ResistanceInsulinLife ExpectancyReceptors, Cytoplasmic and NuclearTranscription, GeneticXenobioticsDrosophila ProteinsHr96 protein, DrosophilaInsulinReceptors, Cytoplasmic and NuclearXenobioticsDHR96IISlifespannuclear hormone receptorxenobiotic resistance

Identifiers

PMID26787908
PMCPMC4747718
OpenAlexW2261050402

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.